Bio Tech/Life SciencesHealthtechB2B2C1-5 employees
Female Founder
PhD FounderAbout
MyoGene Bio is a biotech startup on a mission to develop life-saving therapies for patients with muscle diseases. Our lead program is a gene editing therapy for Duchenne muscular dystrophy.
Traction & Metrics
Custom Metrics
10M
Non-dilutive funding
Products
MyoDys45-55
Gene editing therapy for Duchenne muscular dystrophy
Updates
Selected for TechCrunch Startup Battlefield
Funding raised
Investment
$1.4M